Abstract

Three novel binary copper(II) complexes 1 [Cu(L1)2], 2 [Cu(L2)2] and 3 [Cu(L3)2] where, L1 (1-((E)-(3,5-dimethylisoxazol-4-ylimino)methyl)naphthalen-2-ol, C16H14N2O2), L2 (2-((E)-(3,5-dimethylisoxazol-4-ylimino)methyl)-4-methoxyphenol, C13H14N2O3) and L3 (2-((E)-(3,5-dimethylisoxazol-4-ylimino)methyl)-4-bromophenol, C12H11BrN2O2) have been synthesized. All Cu(II) complexes have been characterized by elemental analysis, FT-IR, ESI mass, UV–Vis, ESR, TG-DTA, magnetic moments and single crystal X-ray diffraction studies. Based on spectral studies square planar geometry is assigned for all Cu(II) complexes. Ligand L1, [Cu(L1)2] and [Cu(L2)2] are crystallized and found to be triclinic, orthorhombic and monoclinic crystal systems respectively. The Schiff bases and their Cu(II) complexes have been screened for antibacterial activity and antifungal activity by paper disc method. It is observed that all Cu(II) complexes showed more activity than corresponding Schiff bases. DNA binding and cleavage studies of Cu(II) complexes have also been investigated. It is observed an intercalation mode of binding with CT-DNA and cleavage of supercoiled pBR322 DNA in the presence of H2O2 and UV light.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.